Large-scale testing (Phase 3)WithdrawnNCT01458236
What this trial is testing
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC